ARO-MUC-5AC

N/A

Report date: 2024/12/30 16:42:42
NME

Base Information

Drug NameARO-MUC-5AC
Drug Alias NameARO-MUC-5AC
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionMucin-5AC inhibitorsRNA interference
TargetsMucin-5AC
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveLung Diseases, ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesPolandThailand +[8] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArrowhead Pharmaceuticals Inc
Active IndicationsLung Diseases, Obstructive
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A